- ►shouxi.net S Grinspoon, A Carr - New England Journal of Medicine, 2005 - content.nejm.org From the Program in Nutritional Metabo- lism and the Neuroendocrine Unit, Mas-
sachusetts General Hospital and Harvard Medical School, Boston (SG); and the
HIV, Immunology, and Infectious Diseases Clin- ical Services Unit, St. ... Cited by 426 - Related articles - All 7 versions
MA Noor, T Seneviratne, FT Aweeka, JC Lo, … - Aids, 2002 - journals.lww.com From the From the Department of a Medicine, University of California, the b
Metabolism and Endocrine Sections, San Francisco Department of Veterans Affairs
Medical Center, the Department of c Pharmacology University of California, ... Cited by 218 - Related articles - BL Direct - All 8 versions
- ►hivtri.com [PDF] A Carr - Aids, 2003 - journals.lww.com HIV lipodystrophy is a heterogeneous syndrome, which has yet to be objectively
defined, comprising peripheral lipoatrophy, central fat accumulation and
lipomata, along with hyperlipidaemia, insulin resistance and lactic ... Cited by 175 - Related articles - BL Direct - All 11 versions
M Caron, M Auclair, H Sterlingot, M … - Aids, 2003 - journals.lww.com Skip Navigation Links Home > November 21, 2003 - Volume 17 - Issue 17 > Some HIV
protease inhibitors alter lamin A/C maturation and... ... From the a INSERM U.
402, Faculté de Médecine Saint-Antoine, Paris, and b Laboratoire de ... Cited by 103 - Related articles - BL Direct - All 5 versions
HJ Woerle, PR Mariuz, C Meyer, RC Reichman … - Diabetes, 2003 - Am Diabetes Assoc The mechanisms responsible for the deterioration in glucose tolerance associated
with protease inhibitor–containing regimens in HIV infection are unclear.
Insulin resistance has been implicated as a major factor, but the affected ... Cited by 97 - Related articles - BL Direct - All 9 versions
D Nolan, M John, S Mallal - Antiviral therapy(London), 2001 - cat.inist.fr Clinical research has indicated that the use of nucleoside reverse transcriptase
inhibitor(NRTI) and HIV protease inhibitor(PI) therapy is associated with a risk
of long-term toxicity syndromes, and that the aetiopathogenesis of these ... Cited by 81 - Related articles - BL Direct - All 4 versions
- ►physiology.org JA Johnson, JB Albu, ES Engelson, SK Fried, … - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc The lipodystrophy syndrome (adipose tissue redistribution and metabolic
abnormalities) observed with highly active antiretroviral therapy (HAART) during
human immunodeficiency virus (HIV) infection may be related to increased ... Cited by 69 - Related articles - BL Direct - All 5 versions
- ►endojournals.org Q Tong, JL Sankale, CM Hadigan, G Tan, ES … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc HIV-related lipodystrophy is characterized by adipose redistribution,
dyslipidemia, and insulin resistance. Adiponectin is an adipose-derived peptide
thought to act as a systemic regulator of glucose and lipid metabolism. We ... Cited by 68 - Related articles - BL Direct - All 4 versions
- ►nih.gov GMN Behrens, AR Boerner, K Weber, J van … - Journal of Clinical Investigation, 2002 - Am Soc Clin Investig Insulin resistance is a frequently observed side effect of highly active
antiretroviral therapy (HAART). Currently, very little is known about the
mechanisms or specific tissues involved. We aimed to identify possible ... Cited by 67 - Related articles - BL Direct - All 7 versions
A Xu, S Yin, LC Wong, K Weng Chan, KSL … - Endocrinology, 2004 - Endocrine Soc Although the clinical application of HIV protease inhibitors (PIs) has markedly
reduced HIV-related morbidity and mortality, it is now recognized that PI-based
therapy often causes serious metabolic disorders, including hyperlipidemia ... Cited by 65 - Related articles - BL Direct - All 4 versions
